A Study Comparing GSK2118436 to Dacarbazine (DTIC) in Previously Untreated Subjects With BRAF Mutation Positive Advanced (Stage III) or Metastatic (Stage IV) Melanoma
Clinical trial NCT01227889 · COMPLETED
Trial details
- NCT number
- NCT01227889
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-23
- Primary completion
- 2011-12-19
- Enrollment
- 251
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.